Signaling pathways
-
BA9228 TrachelosideSummary: Tracheloside is an anti-estrogenic lignan. -
BA9229 FLTX1Summary: FLTX1 is a fluorescent tamoxifen (Tamoxifen) derivative that specifically labels intracellular Tamoxifen binding sites (estrogen receptors) under permeabilizing and non-permeabilizing conditions. - BA9230 AcolbifeneSummary: Acolbifene (EM-652), the active metabolite of EM800, is an orally active pure anti-estrogen and selective antagonist of the estrogen receptor.
- BA9231 PalazestrantSummary: Palazestrant (OP-1250) is an anti-estrogenic and anti-tumor agent.
- BA9232 OP-1074Summary: OP-1074, a pure anti-estrogenic agent, is a selective degrader.
- BA9233 GNE-274Summary: GNE-274 is a structural analog of the ER degradant GDC-0927, a non-degradant.
- BA9234 DS20362725Summary: DS20362725 is an estrogen-related receptor alpha agonist.
- BA9235 PipendoxifeneSummary: A selective estrogen receptor modulators (SERMs).
- BA9237 TPBMSummary: TPBM is a potent inhibitor.
- BA9238 GW7604Summary: GW7604 is an anti-estrogenic drug.